Search Within

Marc Rosenblum

  1. "Maria Arcila"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (4)
  3. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (16)
  2. GSK Faculty (15)
  3. Human Oncology and Pathogenesis Program (15)
  4. Tow Center for Developmental Oncology (TCDO) (15)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (9)
  6. Sloan Kettering Institute Postdocs (8)

More Groups

People
  1. Maria Arcila (16)
  2. Marc Ladanyi (15)
  3. Tejus Bale (11)
  4. Ingo Mellinghoff (9)
  5. Alexandra Miller (8)
  6. Ahmet Zehir (7)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. Journal of Molecular Diagnostics (3)
  2. Neuro-Oncology (3)
  3. Journal of Neuropathology and Experimental Neurology (2)
  4. Laboratory Investigation (2)
  5. Acta Neuropathologica (1)
  6. Acta Neuropathologica Communications (1)

More Publications

Publishers
  1. Oxford University Press (5)
  2. Elsevier Science, Inc. (3)
  3. American Society of Clinical Oncology (2)
  4. Nature Publishing Group (2)
  5. BioMed Central Ltd. (1)
  6. Nature Research (1)

More Publishers

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical sequencing of cell-free DNA from CSF is superior to cell pellet genomic DNA
    Meeting Abstract

    Bale, T.; Solomon, J.; Nafa, K.; Middha, S.; Casanova, J.; Sadowska, J.; Skakodub, A.; Rosenblum, M.; Pentsova, E.; Miller, A.; more...
    Journal of Neuropathology and Experimental Neurology (2019)

    Fulltext@MSK | Save
  • Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Somwar, R.; Rekhtman, N.; Benayed, R.; Chang, J. C.; Plodkowski, A.; Lui, A. J. W.; Eng, J.; Rosenblum, M.; Li, B. T.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay
    Meeting Abstract

    Omuro, A. M. P.; Zehir, A.; Cheng, D. T.; Berger, M. F.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Ladanyi, M.; Arcila, M. E.; Hameed, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Consistent copy number changes and recurrent PRKAR1A mutations distinguish melanotic schwannomas from melanomas: SNP-array and next generation sequencing analysis
    Journal Article

    Wang, L.; Zehir, A.; Sadowska, J.; Zhou, N.; Rosenblum, M.; Busam, K.; Agaram, N.; Travis, W.; Arcila, M.; Dogan, S.; more...
    Genes Chromosomes and Cancer (2015)

    Fulltext@MSK | Save
  • Consistent copy number changes and recurrent PRKAR1A mutations distinguish melanotic schwannomas from melanomas: SNP-array and next generation sequencing analysis
    Meeting Abstract

    Wang, L.; Zehir, A.; Sadowska, J.; Zhou, N.; Rosenblum, M.; Busam, K.; Agaram, N.; Travis, W.; Arcila, M.; Dogan, S.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Consistent copy number changes and recurrent PRKAR1A mutations distinguish melanotic schwannomas from melanomas: SNP-array and next generation sequencing analysis
    Meeting Abstract

    Wang, L.; Zehir, A.; Sadowska, J.; Zhou, N.; Rosenblum, M.; Busam, K.; Agaram, N.; Travis, W.; Arcila, M.; Dogan, S.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save